Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CEBPA Double Mutation”

2 trials

Showing 2 of 2 results

Not applicableLooking for participantsNCT06529250
What this trial is testing

Intermediate-dose HAD Regimen for CEBPA Double-mutated AML

Who this might be right for
AML
Institute of Hematology & Blood Diseases Hospital, China 148
Testing effectiveness (Phase 2)Active Not RecruitingNCT04415008
What this trial is testing

Efficacy of HAD Induction With Intensified Cytarabine in Newly-diagnosed CEBPA Double Mutated Acute Myeloid Leukemia

Who this might be right for
CEBPA Double MutationAcute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China 61

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation